Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

508
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
508
Bioequivalence: Overview01:16

Bioequivalence: Overview

2.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
2.1K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

309
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
309
Clinical Trials01:16

Clinical Trials

11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.0K
Ethics in Research01:56

Ethics in Research

26.0K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
26.0K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

1.3K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Scoping Review of Toolkits Addressing Ethical Issues in Health Registry and Clinical Research Enrollment Among African Americans With CKD.

Kidney medicine·2026
Same author

Development of consensus criteria for problematic medications in active duty service members.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

A Multisite, Randomized Trial Testing a Community-Digital Health Intervention among Black and Latino Adults with Cardiometabolic Conditions: The Roots of Wellness (Raíces del Bienestar) Protocol.

medRxiv : the preprint server for health sciences·2026
Same author

What Is Important to Patients? A Mixed Methods Study to Understand Patient Experience Commonalities Across Three Conditions.

The patient·2026
Same author

Neighborhood Deprivation and Days Spent at Home After Fall-Related Hip Fracture.

JAMA network open·2026
Same author

Five Nested Dolls Framework: enhancing transparency and collaboration in community-engaged research through researcher's reflexivity and disclosure.

BMJ open·2025

Related Experiment Video

Updated: Mar 2, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

13.6K

Querying stakeholders to inform comparative effectiveness research.

Yoon Duk Hong1, Daisuke Goto1, C Daniel Mullins1

  • 1Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD, USA.

Journal of Comparative Effectiveness Research
|May 10, 2017
PubMed
Summary
This summary is machine-generated.

This guide offers practical questions for engaging patients, providers, policymakers, and payers throughout comparative effectiveness research (CER). It supports shared decision-making for patient-centered CER design, conduct, and dissemination.

Keywords:
comparative effectiveness researchstakeholder engagementstakeholder views

More Related Videos

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.7K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K

Related Experiment Videos

Last Updated: Mar 2, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

13.6K
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.7K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K

Area of Science:

  • Health Services Research
  • Translational Science
  • Evidence-Based Practice

Background:

  • Stakeholder engagement is increasingly valued in research.
  • Limited guidance exists for eliciting stakeholder views in comparative effectiveness research (CER).
  • Effective CER requires incorporating diverse perspectives.

Purpose of the Study:

  • To outline the roles of patients, providers, policymakers, and payers in CER.
  • To provide practical questions for engaging stakeholders at each CER stage.
  • To foster shared decision-making for patient-centered CER.

Main Methods:

  • Literature review on stakeholder engagement in CER.
  • Development of practical questions for key stakeholder groups.
  • Framework for integrating stakeholder input throughout the CER process.

Main Results:

  • Defined roles for patients, providers, policymakers, and payers in CER.
  • Provided specific, actionable questions for researcher-stakeholder interaction.
  • Highlighted opportunities for shared decision-making across CER phases.

Conclusions:

  • Implementing this guide can enhance the patient-centeredness of CER.
  • Meaningful stakeholder engagement improves the relevance and applicability of research findings.
  • This framework supports the design, conduct, and dissemination of impactful CER.